Sushil Patel, CEO of Replimune Group Inc. ($REPL), sold shares on the open market twice in the past year, totaling $314 thousand. His most recent sale occurred on December 2, 2025. These sales rank 7,441st among over 11,678 insiders, below the average of 8.6 million per seller and 6 transactions. Patel made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | A | Common Stock | 200000 | $0.00 | 533,576.0000 | 91,915,769 | 59.96% | 0.22% |
| Dec. 2, 2025 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | S | Common Stock | 10000 | $11.13 | 333,576.0000 | 91,915,769 | 2.91% | 0.01% |
| June 26, 2025 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Common Stock | 3142 | $0.00 | 23,090.0000 | 185,913,326 | 15.75% | 0.00% |
| June 26, 2025 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Stock Option (Right to Buy) | 11574 | $0.00 | 11,574.0000 | 185,913,326 | 9999.99% | 0.01% |
| May 20, 2025 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | S | Common Stock | 25105 | $8.06 | 343,576.0000 | 80,564,147 | 6.81% | 0.03% |
| April 1, 2025 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 80,564,147 | 9999.99% | 0.31% |
| April 1, 2025 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | A | Common Stock | 166667 | $0.00 | 368,681.0000 | 80,564,147 | 82.50% | 0.21% |
| Dec. 16, 2024 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | S | Common Stock | 10000 | $12.42 | 202,014.0000 | 78,570,135 | 4.72% | 0.01% |
| Oct. 31, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | S | Common Stock | 5000 | $54.14 | 19,948.0000 | 0 | 20.04% | 0.00% |
| Oct. 31, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Common Stock | 5000 | $24.84 | 24,948.0000 | 0 | 25.07% | 0.00% |
| Oct. 31, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 13,400.0000 | 0 | 27.17% | 0.00% |
| July 9, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | S | Common Stock | 2155 | $44.00 | 19,948.0000 | 0 | 9.75% | 0.00% |
| July 9, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Common Stock | 2155 | $16.80 | 22,103.0000 | 0 | 10.80% | 0.00% |
| July 9, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Stock Option (Right to Buy) | 2155 | $0.00 | 32,490.0000 | 0 | 6.22% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Common Stock | 4248 | $0.00 | 19,948.0000 | 0 | 27.06% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Stock Option (Right to Buy) | 15955 | $0.00 | 15,955.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Stock Option (Right to Buy) | 16700 | $0.00 | 16,700.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Common Stock | 4800 | $0.00 | 20,500.0000 | 0 | 30.57% | 0.00% |
| May 16, 2024 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | S | Common Stock | 20194 | $6.47 | 212,014.0000 | 66,569,894 | 8.70% | 0.03% |
| April 10, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | S | Common Stock | 2155 | $37.00 | 15,700.0000 | 0 | 12.07% | 0.00% |
| April 10, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Common Stock | 2155 | $16.80 | 17,855.0000 | 0 | 13.73% | 0.00% |
| April 10, 2024 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | M | Stock Option (Right to Buy) | 2155 | $0.00 | 34,645.0000 | 0 | 5.86% | 0.00% |
| April 1, 2024 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 66,569,894 | 9999.99% | 0.38% |
| April 1, 2024 | Replimune Group, Inc. | $REPL | Patel Sushil | Chief Executive Officer | A | Common Stock | 83335 | $0.00 | 232,208.0000 | 66,569,894 | 55.98% | 0.13% |
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Stock Option (Right to Buy) | 18400 | $0.00 | 18,400.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | Patel Sushil | Not found | A | Common Stock | 5200 | $0.00 | 15,700.0000 | 0 | 49.52% | 0.00% |